Has Thomas Reeve, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,366 in general payments to Thomas Reeve, MD across 40 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Reeve, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Reeve, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Reeve, MD

Vascular Surgery · Carrollton, GANPI 1992940217

Payments from drug & device makers

$4,366in general payments, 2019–2025

Across 40 payments — averaging $109.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$2K
Degen Medical, Inc.$2K
Globus Medical$264
Penumbra, Inc.$195
Cook Medical LLC$172
Artivion, Inc.$132
plus $176 from 3 others

What the payments were for

Grants$1,12226%
Travel & lodging$1,73140%
Food & beverage$1,51235%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	22	$1,813
Degen Medical, Inc.	1	$1,614
Globus Medical	4	$264
Penumbra, Inc.	2	$195
Cook Medical LLC	1	$172
Artivion, Inc.	3	$132
Cardiovascular Systems Inc.	2	$98
W. L. Gore & Associates, Inc.	4	$63
Innovation Technologies Inc	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,366 in reported general payments places this provider in the 35th percentile of 176 vascular surgery providers in Georgia.

See all vascular surgery providers in Georgia →

Medicare billing

Part B allowed, 2024

$203,517

Medicare patients

442

Services billed

1,071

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XareltoRivaroxaban	41	$27,257
Cilostazol	55	$488
Atorvastatin Calcium	90	$423
ClopidogrelClopidogrel Bisulfate	60	$390
Gabapentin	60	$352
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	49	$204

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Carrollton

Suman AnnambhotlaGainesville$986K
Siddharth PatelAtlanta$381K
Yazan DuwayriAtlanta$284K
Houman TamaddonAugusta$242K
William JordanAugusta$211K
Charles RossAtlanta$178K
Juan AyerdiColumbus$130K
Steven OweidaMarietta$114K
Albert RichardsonThomasville$103K
Andrew UnzeitigAtlanta$96K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →